Portland, ME January 12, 2021 – Chalkline, Inc. has published a Case Study on TowerPinkster’s evaluation, selection, and success of deploying and using VisiSpecs.
TowerPinkster wanted to better utilize their BIM models to create and keep in sync the design specifications. After evaluating spec applications, the decision to select VisiSpecs was easy based on the ease of migrating their current specs, the short learning curve, and time saving features over their old process. Distributing the spec writing tasks across the firm to a diverse user base who might only use the tools a few times in a year required intuitive and easy to use tools. “Our users editing specifications have all given positive feedback reinforcing our decision to go with VisiSpecs,” stated Lyal Ward, Senior Mechanical Engineer at TowerPinkster.
Read the complete Case Study and other customer testimonials here.
Visit www.chalklineinc.com or email firstname.lastname@example.org to learn more about the VisiSpecs applications, request a free trial, register for live webinars, see customer testimonials, and download product information.
About Chalkline, Inc.
Chalkline is the developer of VisiSpecsTM, the next generation suite of applications to visually document, coordinate, and verify the BIM models and project specifications. The technology visionary award winning VisiSpecs is a hybrid cloud solution where it’s desktop and mobile applications store and access the model and specification data on the Company's cloud servers for easy access and collaboration among distributed team members. VisiSpecs is built on the familiar applications already in use resulting in minimal training and setup time. Users can easily integrate their own masters and project documents with the project models to accomplish true BIM integration without learning to use complicated model applications and without a lengthy integration process. And for those that do use the model applications, VisiSpecs provides direct, integrated access to the project specifications and documentation. For more information, visit www.chalklineinc.com.